Clinical trial

Investigating the Anti-Human Immunodeficiency Virus (HIV) & Anti-inflammatory…

NCT00308620 · University of Minnesota, Other · Terminated

Key facts

NCT number NCT00308620
Title Investigating the Anti-Human Immunodeficiency Virus (HIV) & Anti-inflammatory Effect of Chloroquine
Official title A Randomized, Pilot Study of the Anti-Viral and Anti-Inflammatory Effects of Chloroquine in Early HIV Infection
Lead sponsor University of Minnesota, Other
Collaborators Minnesota Medical Foundation
Status Terminated
Phase Phase 2/Phase 3
Study type Interventional
Conditions HIV Infections
Intervention type Drug
Interventions chloroquine phosphate, Placebo
Enrollment 13
Start date Mar 1, 2006
Primary completion Dec 1, 2008
Completion Jun 1, 2009
First posted Mar 29, 2006
Last update posted Jun 4, 2020
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies